Gratus Capital LLC Baxter International Inc Transaction History

Gratus Capital LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 30, 2020	SELL	$78.33 - $90.73 $6.73 Million - $7.8 Million	-85,940 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$78.66 - $94.14 $4,719 - $5,648	60 Added 0.07%	85,940 $7.4 Million
Q1 2020 May 01, 2020	SELL	$71.57 - $93.3 $1.59 Million - $2.07 Million	-22,163 Reduced 20.51%	85,880 $6.97 Million
Q4 2019 Feb 07, 2020	BUY	$76.7 - $88.45 $571,338 - $658,864	7,449 Added 7.41%	108,043 $9.04 Million
Q3 2019 Oct 30, 2019	BUY	$81.4 - $89.78 $108,099 - $119,227	1,328 Added 1.34%	100,594 $8.8 Million
Q2 2019 Aug 07, 2019	BUY	$73.44 - $82.41 $111,555 - $125,180	1,519 Added 1.55%	99,266 $8.13 Million
Q1 2019 May 14, 2019	BUY	$64.48 - $81.31 $6.3 Million - $7.95 Million	97,747 New	97,747 $7.95 Million

1,008

451M

2.79M

2.44M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Gratus Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Gratus Capital LLC with notifications on news.